DRW Securities’s Janux Therapeutics JANX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-19,749
Closed -$303K – 1109
2026
Q2
$303K Buy
+19,749
New +$286K 0.01% 613
2025
Q4
– Sell
-21,543
Closed -$517K – 1461
2025
Q3
$517K Buy
21,543
+8,977
+71% +$219K 0.01% 594
2025
Q2
$290K Buy
+12,566
New +$331K 0.01% 753

Other funds holding JANX

DRW Securities's JANX Position: Q3 2026 in Review

DRW Securities sold out of Janux Therapeutics (JANX) in Q3 2026, closing a stake of 19,749 shares — an estimated $303K sold.

DRW Securities first reported a position in JANX in Q2 2025 and held it in 3 quarters. The position peaked at $517K in Q3 2025. 204 funds tracked by Wall St. Rank hold JANX as of Q3 2026.

  • DRW Securities reported no remaining Janux Therapeutics position as of Q3 2026 after selling out during the quarter.
  • DRW Securities sold 19,749 Janux Therapeutics shares in Q3 2026, an estimated $303K.
  • DRW Securities first reported a position in Janux Therapeutics in Q2 2025 and held it in 3 quarters.
  • DRW Securities's Janux Therapeutics position peaked at $517K in Q3 2025.
  • 204 funds tracked by Wall St. Rank held Janux Therapeutics as of Q3 2026.

Based on DRW Securities's 13F filing for Q3 2026, filed 13 Nov 2026.